Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 319-331

  Iancu, Emanuela M ^a   Corthesy, Patricia ^a   Baumgaertner, Petra ^b   Devevre, Estelle ^b   Voelter, Verena ^a   Romero, Pedro ^b   Speiser, Daniel E ^b   Rufer, Nathalie ^a,b  

^a Multidisciplinary Oncology Center   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; VIRUS DNA; CANCER VACCINE; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; EPITOPE; HERPES VACCINE; LYMPHOCYTE ANTIGEN RECEPTOR; MATRIX PROTEIN; PHOSPHOPROTEIN; SM PROTEIN, HUMAN HERPESVIRUS 4; TRANSACTIVATOR PROTEIN;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL SPECIFICITY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; STEADY STATE; T LYMPHOCYTE SUBPOPULATION; CELL AGING; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOGENICITY; SYNTHESIS; TIME; VIROLOGY; VIRUS INFECTION;

ADULT; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL DIFFERENTIATION; CELLS, CULTURED; CLONE CELLS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS VACCINES; HUMANS; MIDDLE AGED; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TIME FACTORS; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS;

EID: 68949086507     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803647     Document Type: Article

References (52)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60. (Pubitemid 26110754)
2. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. (Pubitemid 129515761)
3. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
4. + T lymphocytes in healthy seropositive donors. J. Virol. 74: 8140-8150.
5. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106-111.
6. + T cells in healthy and immunosuppressed virus carriers. Blood 98: 754-761.
7. + T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 167: 2019-2029.
8. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
9. + T cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2: E20.
10. + T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur. J. Immunol. 34: 999-1010.
11. + T subsets with distinct replicative history and partial effector functions. Blood 102: 1779-1787.
12. + T lymphocytes. J. Immunol. 178: 4112-4119.
13. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
14. + T cell subsets identified by expression of IL-7 receptor α and CD62L. J. Immunol. 175: 4686-4696.
15. + T cells and antiviral protection. J. Immunol. 175: 4677-4685.
16. Roberts, A. D., K. H. Ely, and D. L. Woodland. 2005. Differential contributions of central and effector memory T cells to recall responses. J. Exp. Med. 202: 123-133.
17. + T cells during the primary immune response to Epstein- Barr virus In vivo. J. Exp. Med. 187: 1395-1402.
18. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162: 1827-1835.
19. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195: 893-905.
20. Chen, G., P. Shankar, C. Lange, H. Valdez, P. R. Skolnik, L. Wu, N. Manjunath, and J. Lieberman. 2001. CD8 T cells specific for human immunodeficiency virus: Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98: 156-164.
21. Khan, N., A. Hislop, N. Gudgeon, M. Cobbold, R. Khanna, L. Nayak, A. B. Rickinson, and P. A. Moss. 2004. Herpes virus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173: 7481-7489.
22. + T cell response. J. Immunol. 168: 5455-5464.
23. + T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J. Infect. Dis. 185: 1025-1034.
24. Steven, N. M., N. E. Annels, A. Kumar, A. M. Leese, M. G. Kurilla, and A. B. Rickinson. 1997. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185: 1605-1617.
25. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T cell receptor usage of pp65-specific CTL. J. Virol. 70: 7569-7579.
26. Lim, A., L. Trautmann, M. A. Peyrat, C. Couedel, F. Davodeau, F. Romagne, P. Kourilsky, and M. Bonneville. 2000. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J. Immunol. 165: 2001-2011.
27. Annels, N. E., M. F. Callan, L. Tan, and A. B. Rickinson. 2000. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J. Immunol. 165: 4831-4841.
28. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
29. Trautmann, L., N. Labarriere, F. Jotereau, V. Karanikas, N. Gervois, T. Connerotte, P. Coulie, and M. Bonneville. 2002. Dominant TCR Vα usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur. J. Immunol. 32: 3181-3190.
30. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, V. Cerundolo, and M. Bonneville. 2005. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175: 6123-6132.
31. Romero, P., P. R. Dunbar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Lienard, J. C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188: 1641-1650.
32. + T subsets based on gene expression and replicative history analysis. Methods Mol. Med. 109: 265-284.
33. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Human T cell receptor variable gene segment families. Immunogenetics 42: 455-500. (Pubitemid 26025063)
34. Roux, E., C. Helg, F. Dumont-Girard, B. Chapuis, M. Jeannet, and E. Roosnek. 1996. Analysis of T cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T cell-depleted and unmanipulated grafts. Blood 87: 3984-3992. (Pubitemid 26129632)
35. Speiser, D. E., P. Baumgaertner, C. Barbey, V. Rubio-Godoy, A. Moulin, P. Corthesy, E. Devevre, P. Y. Dietrich, D. Rimoldi, D. Lienard, et al. 2006. A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination. J. Immunol. 177: 1338-1348.
36. + T cell clonotypes is not limited by replicative senescence or functional alteration. J. Immunol. 179: 2368-2379.
37. Pittet, M. J., V. Rubio-Godoy, G. Bioley, P. Guillaume, P. Batard, D. Speiser, I. Luescher, J. C. Cerottini, P. Romero, and A. Zippelius. 2003. α3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells. J. Immunol. 171: 1844-1849.
38. Chattopadhyay, P. K., M. R. Betts, D. A. Price, E. Gostick, H. Horton, M. Roederer, and S. C. De Rosa. 2009. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukocyte Biol. 85: 88-97.
39. + T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J. Immunol. 179: 3203-3213.
40. Bouneaud, C., Z. Garcia, P. Kourilsky, and C. Pannetier. 2005. Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo. J. Exp. Med. 201: 579-590.
41. high memory T cells. Proc. Natl. Acad. Sci. USA 103: 9184-9189.
42. + T cells in acute infectious mononucleosis. Nat. Med. 2: 906-911.
43. Silins, S. L., S. M. Cross, S. L. Elliott, S. J. Pye, S. R. Burrows, J. M. Burrows, D. J. Moss, V. P. Argaet, and I. S. Misko. 1996. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J. Exp. Med. 184: 1815-1824.
44. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer- Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
45. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
46. Couedel, C., M. Bodinier, M. A. Peyrat, M. Bonneville, F. Davodeau, and F. Lang. 1999. Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity: CD8 variable contribution compensating for differences in TCR affinities. J. Immunol. 162: 6351-6358.
47. Levitsky, V., P. O. de Campos-Lima, T. Frisan, and M. G. Masucci. 1998. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time. J. Immunol. 161: 594-601. (Pubitemid 28323519)
48. + CTL in persons with frequently recurring genital herpes. J. Immunol. 165: 1146-1152.
49. Cohen, G. B., S. A. Islam, M. S. Noble, C. Lau, C. Brander, M. A. Altfeld, E. S. Rosenberg, J. E. Schmitz, T. O. Cameron, and S. A. Kalams. 2002. Clonotype tracking of TCR repertoires during chronic virus infections. Virology 304: 474-484.
50. + T cells can dominate in the peripheral circulation for at least 18 years. Blood 106: 4412-4413.
51. + cell clonotypes in infected tissues and blood. J. Infect. Dis. 191: 2012-2021.
52. Zhang, D., P. Shankar, Z. Xu, B. Harnisch, G. Chen, C. Lange, S. J. Lee, H. Valdez, M. M. Lederman, and J. Lieberman. 2003. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 101: 226-235.